Startups
Medicortex Finland Oy is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including brain injury and concussion. One of the company's missions is to identify a new biomarker in order to reliably assess the severity and extent of brain injury. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a privately owned company. Dr. Harel has a track record in the business management and leadership of early-stage biotechnology companies.
----
Kuvaus suomeksi:
Medicortex Finland Oy (http://www.medicortex.fi) on bioteknologian alan yritys, joka on keskittynyt parantamaan aivovammojen (TBI) diagnostiikka ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.
----
Kuvaus suomeksi:
Medicortex Finland Oy (http://www.medicortex.fi) on bioteknologian alan yritys, joka on keskittynyt parantamaan aivovammojen (TBI) diagnostiikka ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.
Overview
Location
Finland, Mainland Finland, Turku
Employees
1-10
Founded date
2014
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 30, 2026 | #26-48 NOSIUM AB has changed its name to Medicortex International AB | #26-48 NOSIUM AB has changed its name to Medicortex International AB Tue, Jun 30, 2026 15:11 CET Report this content NOSIUM AB, whose shares are listed on NGM Growth Market, has changed its name to Medicortex International AB. New Listing n... |
| Jun 30, 2026 | #26-49 Correction of NGM Market Notice 26-48 regarding share class | #26-49 Correction of NGM Market Notice 26-48 regarding share class Tue, Jun 30, 2026 17:26 CET Report this content Correction regarding the new listing name and exchange symbol, correct listing name is Medicortex International B and exchang... |
| Feb 27, 2023 | Startup Showcase: Medicortex Finland Oy – Revolutionizing Brain Injury Diagnosis | Traumatic Brain Injury (TBI) is a serious and complex medical condition that affects millions of people worldwide each year. Early and accurate diagnosis is critical in determining the course of treatment and improving patient outcomes. How... |
| Sep 29, 2021 | Medicortex Closes Half Million Euro Pre-IPO Funding Round | Medicortex Finland Oy, a Turku, Finland-based biotechnology company developing diagnostic tests for brain injury, closed a pre-IPO share issue round of half million euro. Existing shareholders and new investors participated in the round. Th... |
Reviews 0
FAQ about Medicortex Finland Oy
When was Medicortex Finland Oy founded?
Medicortex Finland Oy was founded in 2014.
What has the press written about Medicortex Finland Oy?
Parsers VC has collected 5 articles mentioning Medicortex Finland Oy, among them “#26-48 NOSIUM AB has changed its name to Medicortex International AB” (Jun 30, 2026) and “#26-49 Correction of NGM Market Notice 26-48 regarding share class” (Jun 30, 2026).
Is Medicortex Finland Oy still active?
Yes, Medicortex Finland Oy is active; its latest activity on Parsers VC dates from Jul 1, 2026.